Six projects will investigate innovative approaches that could help slow Arctic sea ice loss and reduce escalating ...
The journey towards circular high-performance composites begins with one core question: why redesign an already mature class ...
A team of physicists from the University of Ottawa have developed a new theoretical model that shines new light on how ...
Kohei Shitara, MD, discusses CLDN18.2-guided therapy, nivolumab plus zolbetuximab, and toxicity management in advanced ...
The FDA has approved a new, simplified monthly subcutaneous (SC) dosing schedule for amivantamab and hyaluronidase-lpuj (Rybrevant Faspro; Johnson & Johnson) for the treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results